Related Experiment Videos
Should all patients undergo cardiac catheterization after a myocardial infarction?
1Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Insights
Most patients surviving acute myocardial infarction (AMI) can be managed conservatively. Noninvasive testing helps identify high-risk individuals who benefit from further invasive evaluation, avoiding unnecessary procedures for low-risk patients.
Area of Science:
- Cardiology
- Internal Medicine
- Medical Diagnostics
Background:
- A significant proportion of patients surviving acute myocardial infarction (AMI) are at low risk for subsequent complications.
- However, a substantial minority remain at high risk for adverse cardiac events within three months post-AMI, including cardiac death and recurrent myocardial infarction.
Purpose of the Study:
- To evaluate the efficacy of noninvasive risk stratification methods for identifying high-risk patients after AMI.
- To determine the appropriate management strategy, distinguishing between conservative medical therapy and invasive procedures like cardiac catheterization.
Main Methods:
- Utilized clinical evaluation, rest and stress electrocardiograms (ECG) with radionuclide imaging, and two-dimensional stress echocardiography for risk stratification.
- Employed pharmacologic perfusion scintigraphy for patients unable to perform exercise stress tests.
Main Results:
- Noninvasive testing effectively identifies patients at high risk who warrant cardiac catheterization and myocardial revascularization.
- Routine cardiac catheterization for all AMI survivors is not supported by evidence and leads to resource overuse, with similar survival rates observed in countries with selective invasive strategies.
Conclusions:
- Most patients after AMI can be managed conservatively with risk stratification based on noninvasive testing.
- Only selected high-risk patients identified through noninvasive evaluation should proceed to invasive procedures, optimizing resource allocation and patient outcomes.
Abstract:
Between one half and two thirds of patients who survive an acute myocardial infarction (AMI) may be at low risk for future complications and hence can be managed with medical therapy. However, the remaining patients are prone to future complications, which by and large occur within the subsequent 3 months and include cardiac death, recurrent AMI, unstable angina, and congestive heart failure. Current available methods for risk stratification include a good clinical evaluation, rest and stress electrocardiograms (preferentially combined with radionuclide imaging), and possibly two-dimensional stress echocardiography. In patients unable to exercise, pharmacologic perfusion scintigraphy affords a powerful means to identify high-risk patients. Patients deemed to be at high risk should be referred for cardiac catheterization and myocardial revascularization. The practice of performing routine cardiac catheterization after an AMI has led to an over use of resources in the United States. Such a practice is not based on any scientific evidence of enhanced benefit. In fact, in other Western world countries where only selected patients are referred for cardiac catheterization, patient survival appears to be similar to that in the United States. In conclusion, most patients after AMI, whether treated with thrombolytic therapy or not, can be managed conservatively and risk stratified on the basis of noninvasive testing, after which patients deemed to be at high risk should undergo invasive evaluation.